While speaking at an event this past Thursday, President Biden excessively pushed onward for his drive to increase the COVID-19 vaccination rate for children between the ages of five through eleven. This is all in spite of multiple polls that show that almost half of parents across American seem to oppose the idea.
At the event, Biden stated, “Families will be able to sleep easier at night knowing their kids are protected.”
Old Uncle Joe continued:
Now I know parents out there are anxiously waiting for a vaccine for children ages five to eleven. The good news is the FDA and outside experts from the CDC are set to make this determination as to whether the vaccine will be authorized for that age range in the next few weeks.
If authorized, we are ready. We have purchased enough vaccines for all children, between the ages of 5 and 11, in the United States. It will be convenient for parents to get their children vaccinated at trusted locations, and families will be able to sleep easier at night knowing their kids are protected.
A poll conducted by CBS News/YouGov back between the 6th through the eighth of October and discovered that well over 61% of all parents who were currently unvaccinated were against the vaccination of their kids between the ages of 5-11, and almost the exact opposite showed true for vaccinated parents where 61% of those who were vaccinated would, in fact, vaccinate their kids in the same age group.
In another Gallup poll that took place at the end of September discovered that almost a majority of parents were set against the vaccination of children under the age of 12 where almost 45% were against such an idea.
The White House has sent messages to governors to start getting ready to put forth a plan to vaccinate children in their states as young as five years old.
“The Biden administration has purchased 65 million pediatric doses of the Pfizer/BioNTech vaccine, enough to vaccinate the estimated 28 million children who would be eligible should the Food and Drug Administration approve Pfizer’s request to vaccinate children ages 5 to 11, said an official of the Department of Health and Human Services,” stated NBC News.
At an upcoming event set to take place on October 26th, an independent expert panel will be holding a public debate on the issue.
“Pfizer and its partner company BioNTech are awaiting an expert review for the vaccine, which is scheduled for October 26th,” Noted the Daily Wire. “Pfizer conducted a study of over 2,000 children and found no serious side effects, though the company admitted its study was not large enough to detect rarer side effects like the heart inflammation that presents very rarely in young men after they’ve received the second dose of the vaccine.”